The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells.
Open accessAbstract
A polypeptide termed oncostatin M, which inhibits the replication of A375 melanoma and other human tumor cells, but not normal human fibroblasts, has been isolated from serum-free supernatants of U-937 histiocytic lymphoma cells that have been induced to differentiate into macrophage-like cells following treatment with the phorbol ester phorbol 12-myristate 13-acetate. No such growth inhibitory activity is detected in the supernatant of untreated U-937 cells, indicating that the protein is induced or increased in expression in the phorbol ester-induced differentiated cells. Oncostatin M is stable between pH 2 and 11 and after heating for 1 hr at 56 degrees C but is not stable at 90 degrees C. Purification of oncostatin M has been achieved by gel chromatography and reversed-phase HPLC, using sequentially acetonitrile and n-propanol in the presence of aqueous trifluoroacetic acid. The apparent molecular weight of oncostatin M is approximately 18,000, as determined by gel chromatography, and 28,000, as determined by polyacrylamide gel electrophoresis. The amino-terminal amino acid sequence of the purified polypeptide has been determined. No substantial sequence homology between oncostatin M and other proteins was found, including other tumor cell inhibitory proteins produced by mononuclear cells. Oncostatin M, therefore, appears to represent a distinct cell growth regulator.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Edman, P., & Begg, G. (1967) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1967.tb00047.x · Cited by 2,845
Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)
Sundström, C., & Nilsson, K. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170504 · Cited by 2,407
Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., & Parks, W. P. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1417 · Cited by 2,289
Self-citationA gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., & Shepard, H. M. (1985) · Science · doi:10.1126/science.3933111 · Cited by 1,580
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V., Gillis, S., Henney, C. S., Kronheim, S. R., Grabstein, K., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,579
Rapid similarity searches of nucleic acid and protein data banks.
Wilbur, W. J., & Lipman, D. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.3.726 · Cited by 1,546
Handbook of experimental pharmacology
(1984) · International Journal of Biochemistry · doi:10.1016/0020-711x(84)90023-5 · Cited by 1,417
Hunkapiller, M. W., Lujan, E., Ostrander, F., & Hood, L. E. (1983) · Methods in Enzymology · doi:10.1016/s0076-6879(83)91019-4 · Cited by 1,105
Type beta transforming growth factor: a bifunctional regulator of cellular growth.
Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F., & Sporn, M. B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.119 · Cited by 1,094
Expression of human immune interferon cDNA in E. coli and monkey cells
Gray, P. W., Leung, D. W., Pennica, D., Yelverton, E., Najarian, R., Simonsen, C. C., Derynck, R., Sherwood, P. J., Wallace, D. M., Berger, S. L., et al. (1982) · Nature · doi:10.1038/295503a0 · Cited by 689
NK Cells and Other Natural Effector Cells
(1982) · Elsevier eBooks · doi:10.1016/c2012-0-01556-6 · Cited by 623
The murine transforming growth factor-beta precursor.
Derynck, R., Jarrett, J. A., Chen, E. Y., & Goeddel, D. V. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38511-3 · Cited by 472
Carey, T. E., Takahashi, T., Resnick, L. A., Oettgen, H. F., & Old, L. J. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3278 · Cited by 438
Endotoxin and Double Stranded RNA render Macrophages Cytotoxic
ALEXANDER, P., & EVANS, R. (1971) · Nature New Biology · doi:10.1038/newbio232076a0 · Cited by 438
Human interleukin 1 is a cytocidal factor for several tumor cell lines.
Onozaki, K., Matsushima, K., Aggarwal, B. B., & Oppenheim, J. J. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3962 · Cited by 372
(1985) · PubMed · Cited by 346
Weissenbach, J., Chernajovsky, Y., Zeevi, M., Shulman, L., Soreq, H., Nir, U., Wallach, D., Perricaudet, M., Tiollais, P., & Revel, M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7152 · Cited by 335
Fidler, I. J., Sone, S., Fogler, W. E., & Barnes, Z. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.3.1680 · Cited by 324
Lymphokine-activated killer cells: A new approach to immunotherapy of cancer
(1985) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/75.4.595 · Cited by 308
Human leukocyte and fibroblast interferons are structurally related
Taniguchi, T., Mantei, N., Schwarzstein, M., Nagata, S., Muramatsu, M., & Weissmann, C. (1980) · Nature · doi:10.1038/285547a0 · Cited by 277
A family of structural genes for human lymphoblastoid (leukocyte-type) interferon
Allen, G., & Fantes, K. H. (1980) · Nature · doi:10.1038/287408a0 · Cited by 251
Degliantoni, G., Murphy, M., Kobayashi, M., Francis, M. K., Perussia, B., & Trinchieri, G. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.5.1512 · Cited by 239
Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells.
Lachman, L. B., Dinarello, C. A., Llansa, N. D., & Fidler, I. J. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.8.3098 · Cited by 202
Cytolytic and cytostatic activity on tumor cells of circulating human monocytes
Mantovani, A., Jerrells, T. R., Dean, J. H., & Herberman, R. B. (1979) · International Journal of Cancer · doi:10.1002/ijc.2910230105 · Cited by 173
Protein Sequence Analysis: Automated Microsequencing
Hunkapiller, M. W., & Hood, L. E. (1983) · Science · doi:10.1126/science.6687410 · Cited by 162
Purification and Properties of Human Lymphocyte Activating Factor (LAF)
Blyden, G. T., & Handschumacher, R. E. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.118.5.1631 · Cited by 152
Barker, W. C., George, D. G., & Hunt, L. T. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)83005-t · Cited by 108
Harris, P. E., Ralph, P., Litcofsky, P. B., & Moore, M. A. S. (1985) · Cancer Research · Cited by 95
Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
Iwata, K. K., Fryling, C. M., Knott, W. B., & Todaro, G. J. (1985) · PubMed · Cited by 67
Self-citationAmino-terminal amino acid sequence of human leukocyte interferon.
Levy, W. P., Shively, J. E., Rubinstein, M., Valle, U. D., & Pestka, S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5102 · Cited by 66
Autocrine growth inhibition of a cloned line of helper T cells.
Horowitz, J. B., Kaye, J., Conrad, P. J., Katz, M., & Janeway, C. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1886 · Cited by 50
Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
Fryling, C. M., Iwata, K. K., JOHNSON, P. A., et al. (1985) · PubMed · Cited by 35
Cited by
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
In vitro Hepatic Differentiation of Human Mesenchymal Stem Cells
Lee, K., Kuo, T. K., Whang–Peng, J., Chung, Y., Lin, C., Chou, S., Chen, J., Chen, Y., & Lee, O. K. (2004) · Hepatology · doi:10.1002/hep.20469 · Cited by 865
Interleukin 6 and its receptor: ten years later
Hirano, T. (1998) · International Reviews of Immunology · doi:10.3109/08830189809042997 · Cited by 788
Transforming Growth Factor‐β: Major Role in Regulation of Extracellular Matrix
ROBERTS, A. B., HEINE, U. I., FLANDERS, K. C., & SPORN, M. B. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17931.x · Cited by 696
Interleukin-6 and its receptor: a paradigm for cytokines
Kishimoto, T., Akira, S., & Taga, T. (1992) · Science · doi:10.1126/science.1411569 · Cited by 665
Metadata
- Authors
- Zarling, J. M., Shoyab, M., Marquardt, H., Hanson, M. B., Lioubin, M. N., & Todaro, G. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-12
- Volume
- 83
- Issue
- 24
- Pages
- 9739-9743
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2079814968
- Cited by
- 435
- References
- 38
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.